AUTUMN KIRK: Open Payments
NPI 1912482936 · KNOX, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$302 in 15 payments from 9 companies in 2025. Trend: 2023 $198 · 2024 $185 · 2025 $302
Food & beverage: $302
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $68 |
| AstraZeneca Pharmaceuticals LP | 3 | $64 |
| Novo Nordisk Inc | 2 | $43 |
| Biogen, Inc. | 1 | $27 |
| Axsome Therapeutics, Inc. | 1 | $25 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| Dexcom, Inc. | 1 | $19 |
| Corium, LLC | 1 | $19 |
| Exact Sciences Corporation | 1 | $18 |
Products named: VRAYLAR, AIRSUPRA, Wegovy, SKYCLARYS, Auvelity, JASCAYD, Dexcom G6 Transmitter, Azstarys.
Industry payments across IN — which companies pay providers there.
